Lee Financial CO Bio Rad Laboratories, Inc. Transaction History

Lee Financial CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$359.49 - $486.4 $3,235 - $4,377	9 Added 28.13%	41 $15,000
Q4 2022 Feb 09, 2023	BUY	$351.71 - $456.01 $3,165 - $4,104	9 Added 39.13%	32 $13,000
Q3 2022 Nov 01, 2022	SELL	$412.59 - $563.26 $1,650 - $2,253	-4 Reduced 14.81%	23 $10,000
Q1 2022 May 11, 2022	SELL	$524.57 - $735.42 $9,442 - $13,237	-18 Reduced 40.0%	27 $15,000
Q4 2021 Feb 08, 2022	BUY	$708.84 - $794.68 $4,961 - $5,562	7 Added 18.42%	45 $34,000
Q1 2021 May 13, 2021	BUY	$547.01 - $662.35 $3,829 - $4,636	7 Added 22.58%	38 $22,000
Q2 2020 Aug 11, 2020	SELL	$334.87 - $493.06 $2,678 - $3,944	-8 Reduced 20.51%	31 $14,000
Q1 2019 Apr 30, 2019	BUY	$224.3 - $317.41 $1,794 - $2,539	8 Added 25.81%	39 $12,000
Q3 2018 Nov 07, 2018	BUY	$289.28 - $326.15 $8,967 - $10,110	31 New	31 $10,000

455

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.43B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.